IP Library › Assignment 032630/0080
Patent Assignment
Reel/Frame 032630/0080

Assignment of Assignor's Interest

Recorded: 2014-04-08 Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2009-09-09
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (5)
Method and medicament for inhibiting the expression of a given gene
Patent: 8,877,726 →
Application: 13/656,513 →
Publication: US 2014/0051166
Method and medicament for inhibiting the expression of a given gene
Application: 13/656,540 →
Publication: US 2013/0164366
Method and Medicament for Inhibiting the Expression of a Given Gene
Patent: 9,902,954 →
Application: 13/656,548 →
Publication: US 2013/0164843
Method and Medicament for Inhibiting the Expression of a Given Gene
Patent: 9,133,454 →
Application: 14/218,476 →
Publication: US 2014/0220113
Method and Medicament for Inhibiting the Expression of a Given Gene
Patent: 9,902,955 →
Application: 14/218,489 →
Publication: US 2014/0220676
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 8, 2014
From: KREUTZER, ROLAND; LIMMER, STEFAN
To: RIBOPHARMA AG
Reel/Frame 032630/0047 →
Change of Name Apr 8, 2014
From: RIBOPHARMA AG
To: ALNYLAM EUROPE AG
Reel/Frame 032630/0054 →
Assignment of Assignor's Interest Dec 20, 2017
From: ALNYLAM EUROPE AG
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 044448/0487 →